Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Overview and Scope
Esophageal dysphagia is a medical condition characterized by an indication in difficulty with swallowing solid or liquid food due to a structural or functional abnormality of the esophagus, lower esophageal sphincter (LES), or cardia. It can be caused by various underlying conditions that affect the normal functioning of the esophagus or hinder the smooth passage of food and liquids.

Sizing and Forecast
The esophageal dysphagia market size has grown strongly in recent years. It will grow from $1.96 billion in 2023 to $2.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%.  The  growth in the historic period can be attributed to aging population, gastroesophageal reflux disease (gerd), advances in endoscopy, esophageal motility testing.

The esophageal dysphagia market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%.  The growth in the forecast period can be attributed to obesity epidemic, minimally invasive procedures, personalized medicine, global expansion of esophageal dysphagia care. Major trends in the forecast period include patient-centered care, telehealth and remote monitoring, nutritional support, research collaboration.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/esophageal-dysphagia-global-market-report

Segmentation & Regional Insights
The esophageal dysphagia market covered in this report is segmented –

1) By Treatment: Esophageal Dilation; Surgery; Stent Placement; Laparoscopic Heller Myotomy; Medications; Lifestyle Changes
2) By Diagnosis: Dynamic Swallowing Study; X-Ray; Endoscope; Manometry; Imaging Scans; Magnetic Resonance Imaging (MRI) Scan; Computed Tomography (CT ) Scan
3) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Diagnostic Centers; Research Centers; Other End Users

North America was the largest region in the esophageal dysphagia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in esophageal dysphagia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13036&type=smp

Major Driver Impacting Market Growth
The growing number of smokers is expected to propel the growth of the esophageal dysphagia market going forward. Smokers typically refer to individuals who engage in the habit of smoking tobacco products, such as cigarettes, cigars, or pipes. Esophageal dysphagia can be exacerbated by smoking, which can lead to various health complications, including irritation and damage to the esophagus. The treatment for esophageal dysphagia helps patients suffering from the disease with enhanced nutrition and hydration, reduced risk of aspiration and improved quality of life. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Additionally, the total number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June 2022. As a result, the growing number of smokers is driving the esophageal dysphagia market.

Key Industry Players
Major players in the esophageal dysphagia market are  Nestle Health Science S.A., Novartis AG, Fresenius Kabi AG, Abbott Laboratories, Danone S.A., F. Hoffmann-La Roche Ltd., Merck Sharp and Dohme Corp., Pfizer Inc., Ingredion Incorporated, Eikonix Ltd., Olympus Corporation, Eisai Co. Ltd., Aurobindo Pharma Ltd., Dr. Reddys Laboratories, Cook Medical Incorporated, Elekta AB, Johnson and Johnson Ltd., C.R. Bard Inc., Avanos Medical Inc., Cipla Ltd., Kent Precision Foods Group Inc., Nutricia Ltd., CP Kelco Inc., Atos Medical AB, AstraZeneca PLC, NinePoint Medical Inc., Torax Medical Inc., Hormel Health Labs Inc., Dysphagia Management Systems LLC, Biostage Inc.

The esophageal dysphagia market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis

.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis


Related Reports:

https://goodprnews.com/anoscope-market-forecast/
https://goodprnews.com/dumping-syndrome-market-outlook/
https://topprnews.com/anoscope-market-opportunities/
https://topprnews.com/understanding-industry-dynamics-insights-into-dumping-syndrome-market-growth/

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe